Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global non-invasive prenatal testing market reached a value of US$ 2.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2027, exhibiting a CAGR of 17.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman’s blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother’s blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.

The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global non-invasive prenatal testing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, test type, technology, method, application and end-user.

Breakup by Product Type:

  • Consumables
  • Instruments
     

Breakup by Test Type:

  • Materni 21
  • Harmony
  • Panaroma
  • Verifi
  • NIFTY
  • Others
     

Breakup by Technology:

  • NGS
  • WGS
  • Others
     

Breakup by Method:

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-Free DNA in Maternal Plasma Tests
  • Fetal Cells in Maternal Blood Tests
  • Others
     

Breakup by Application:

  • Trisomy
  • Microdeletion Syndrome
  • Others
     

Breakup by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa


Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the top non invasive prenatal testing companies key players being Agilent Technologies, Inc., Berry Genetics, Inc., BGI Genomics Co., Ltd., Eurofins Scientific Services Limited, F. Hoffmann-La Roche Ltd, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Yourgene Health plc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product Type, Test Type, Technology, Method, Application, End-User, Region
Region Covered North America, Asia Pacific, Europe, Latin America, Middle East and Africa
Countries Covered United States, Canada, China, Japan, India, South Korea, Australia, Indonesia, Germany, France, United Kingdom, Italy, Spain, Russia, Brazil, Mexico
Companies Covered Agilent Technologies, Inc., Berry Genetics, Inc., BGI Genomics Co., Ltd., Eurofins Scientific Services Limited, F. Hoffmann-La Roche Ltd, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Yourgene Health plc
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Non-Invasive Prenatal Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product Type
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Instruments
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Test Type
    7.1    Materni 21
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Harmony
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Panaroma
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Verifi
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    NIFTY
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8   Market Breakup by Technology
    8.1    NGS
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    WGS
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Method
    9.1    Ultrasound Detection
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Biochemical Screening Tests
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Cell-Free DNA in Maternal Plasma Tests
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Fetal Cells in Maternal Blood Tests
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10  Market Breakup by Application
    10.1    Trisomy
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Microdeletion Syndrome
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Others
        10.3.1 Market Trends
        10.3.2 Market Forecast
11  Market Breakup by End-User
    11.1    Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2    Diagnostic Laboratories
        11.2.1 Market Trends
        11.2.2 Market Forecast
    11.3    Others
        11.3.1 Market Trends
        11.3.2 Market Forecast
12  Market Breakup by Region
    12.1    North America
        12.1.1 United States
           12.1.1.1 Market Trends
           12.1.1.2 Market Forecast
        12.1.2 Canada
           12.1.2.1 Market Trends
           12.1.2.2 Market Forecast
    12.2    Asia Pacific
        12.2.1 China
           12.2.1.1 Market Trends
           12.2.1.2 Market Forecast
        12.2.2 Japan
           12.2.2.1 Market Trends
           12.2.2.2 Market Forecast
        12.2.3 India
           12.2.3.1 Market Trends
           12.2.3.2 Market Forecast
        12.2.4 South Korea
           12.2.4.1 Market Trends
           12.2.4.2 Market Forecast
        12.2.5 Australia
           12.2.5.1 Market Trends
           12.2.5.2 Market Forecast
        12.2.6 Indonesia
           12.2.6.1 Market Trends
           12.2.6.2 Market Forecast
        12.2.7 Others
           12.2.7.1 Market Trends
           12.2.7.2 Market Forecast
    12.3    Europe
        12.3.1 Germany
           12.3.1.1 Market Trends
           12.3.1.2 Market Forecast
        12.3.2 France
           12.3.2.1 Market Trends
           12.3.2.2 Market Forecast
        12.3.3 United Kingdom
           12.3.3.1 Market Trends
           12.3.3.2 Market Forecast
        12.3.4 Italy
           12.3.4.1 Market Trends
           12.3.4.2 Market Forecast
        12.3.5 Spain
           12.3.5.1 Market Trends
           12.3.5.2 Market Forecast
        12.3.6 Russia
           12.3.6.1 Market Trends
           12.3.6.2 Market Forecast
        12.3.7 Others
           12.3.7.1 Market Trends
           12.3.7.2 Market Forecast
    12.4    Latin America
        12.4.1 Brazil
           12.4.1.1 Market Trends
           12.4.1.2 Market Forecast
        12.4.2 Mexico
           12.4.2.1 Market Trends
           12.4.2.2 Market Forecast
        12.4.3 Others
           12.4.3.1 Market Trends
           12.4.3.2 Market Forecast
    12.5    Middle East and Africa
        12.5.1 Market Trends
        12.5.2 Market Breakup by Country
        12.5.3 Market Forecast
13  SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14  Value Chain Analysis
15  Porters Five Forces Analysis

    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16  Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Agilent Technologies, Inc.
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis 
        16.3.2    Berry Genetics Inc.
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
        16.3.3    BGI Genomics Co. Ltd.
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
           16.3.3.3 Financials
        16.3.4    Eurofins Scientific Services Limited
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
           16.3.4.3 Financials
        16.3.5    F. Hoffmann-La Roche Ltd
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
           16.3.5.3 SWOT Analysis
        16.3.6    GE Healthcare
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
        16.3.7    Igenomix
           16.3.7.1 Company. Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 Financials
        16.3.8    Illumina Inc.
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis
        16.3.9    Laboratory Corporation
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
           16.3.9.4 SWOT Analysis
        16.3.10    Natera Inc.
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
           16.3.10.3 Financials
        16.3.11    Perkinelmer Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
           16.3.11.4 SWOT Analysis
        16.3.12    Thermo Fisher Scientific Inc.
           16.3.12.1 Company Overview
           16.3.12.2 Product Portfolio
           16.3.12.3 Financials
           16.3.12.4 SWOT Analysis
        16.3.13    Yourgene Health plc
           16.3.13.1 Company Overview
           16.3.13.2 Product Portfolio
           16.3.13.3 Financials
           
List of Figures

Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2021
Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2021
Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2021
Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2021
Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2021
Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2021
Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2021
Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million US$), 2022-2027
Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 9: Global: Non-Invasive Prenatal Testing Market Structure
Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global non-invasive prenatal testing market was valued at US$ 2.9 Billion in 2021.

We expect the global non-invasive prenatal testing market to exhibit a CAGR of 17.4% during 2022-2027.

The high prevalence of genetic disorders, coupled with the introduction of
numerous awareness programs towards the availability of early diagnosis and treatment facilities, is
primarily driving the global non-invasive prenatal testing market.

The sudden outbreak of the COVID-19 pandemic had led to postponement of elective prenatal screening
tests to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical
equipment.

Based on the product type, the global non-invasive prenatal testing market has been segmented into
consumables and instruments, where consumables hold the majority of the total market share.

Based on the test type, the global non-invasive prenatal testing market can be divided into Materni 21,
Harmony, Panaroma, Verifi, NIFTY, and others. Currently, Materni 21 test exhibits a clear dominance in
the market.

Based on the technology, the global non-invasive prenatal testing market has been bifurcated into NGS,
WGS, and others. Among these, NGS technology currently accounts for the majority of the global market
share.

Based on the method, the global non-invasive prenatal testing market can be categorized into
ultrasound detection, biochemical screening tests, cell-free DNA in maternal plasma tests, fetal cells in
maternal blood tests, and others. Currently, cell-free DNA in maternal plasma tests method holds the
largest market share.

Based on the application, the global non-invasive prenatal testing market has been divided into trisomy,
microdeletions syndrome, and others. Among these, trisomy accounts for the majority of the total
market share.

Based on the end-user, the global non-invasive prenatal testing market can be segregated into hospitals,
diagnostic laboratories, and others. Currently, diagnostic laboratories exhibit a clear dominance in the
market.

On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East
and Africa, and Latin America, where North America currently dominates the global market.

Some of the major players in the global non-invasive prenatal testing market include Agilent
Technologies, Inc., Berry Genetics, Inc., BGI Genomics Co., Ltd., Eurofins Scientific Services Limited, F.
Hoffmann-La Roche Ltd, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc.,
PerkinElmer Inc., Thermo Fisher Scientific Inc., and Yourgene Health plc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4